Understanding medication adherence in pediatric acute lymphoblastic leukemia: A review

被引:45
|
作者
Pritchard, Michelle T. [1 ]
Butow, Phyllis N.
Stevens, Michael M.
Duley, John A.
机构
[1] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia
[2] Univ Queensland, Sch Pharm, St Lucia, Qld 4067, Australia
关键词
acute lymphoblastic leukemia; treatment adherence; pediatric; review;
D O I
10.1097/01.mph.0000243666.79303.45
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Significant numbers of children and adolescents with acute lymphoblastic leukemia (ALL) do not adequately adhere to their treatment regimen. Failure to take the appropriate amount of prescribed medication may result in disease relapse. Although a number of research studies have sought to identify the factors associated with medication nonadherence in this group, no systematic study has sought to evaluate the efficacy of intervention packages in improving adherence. The aim of the current paper is to provide an overview of the research investigating treatment adherence in ALL patients and to identify the relevant risk factors associated with reduced adherence with medication. The paper will further discuss the role of psychologic therapy in improving treatment adherence in children and adolescents with ALL, with a particular focus on identifying the need for controlled outcome studies.
引用
收藏
页码:816 / 823
页数:8
相关论文
共 50 条
  • [21] Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding
    Alqahtani, Amani
    Alhousari, Diala
    Ali, Amir
    Yaghmour, George
    Orgel, Etan
    Curran, Emily
    Stock, Wendy
    Bhojwani, Deepa
    Alachkar, Houda
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (06) : 357 - 366
  • [22] Erwinia Asparaginase: Coming Closer to an Understanding of Its Use in Pediatric Acute Lymphoblastic Leukemia?
    Maloney, Kelly W.
    PEDIATRIC BLOOD & CANCER, 2010, 54 (02) : 189 - 190
  • [23] Adherence to mercaptopurine (6-MP) and habit strength in pediatric acute lymphoblastic leukemia (ALL)
    Yang, Mira
    Badawy, Sherif Mohamed
    Singh, Revika
    King, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Assessment of medication compliance in children with acute lymphoblastic leukemia
    Pradhan, KR
    Harley, J
    Vik, TA
    Eskew, JA
    Murray, MD
    Breitfeld, PP
    PEDIATRIC RESEARCH, 2003, 53 (04) : 291A - 291A
  • [25] MEDICATION ERRORS IN ORAL CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Oberoi, Sapna
    Trehan, Amita
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 732 - 732
  • [26] CNS prophylaxis in pediatric acute lymphoblastic leukemia
    Sison, Edward Allan R.
    Silverman, Lewis B.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 198 - 201
  • [27] Genomic Heterogeneity In Pediatric Acute Lymphoblastic Leukemia
    Yaniv, Isaac
    Jeison, Marta
    Hameiri-Grossman, Michal
    Mardoukh, Jacque
    Sharon, Nir Adam
    Elitzur, Sarah
    Gilad, Gil
    Avrahami, Gali
    Stark, Batia
    Avigad, Smadar
    BLOOD, 2013, 122 (21)
  • [28] Mechanism of relapse in pediatric acute lymphoblastic leukemia
    Henderson, Michelle J.
    Choi, Seoyeon
    Beesley, Alex H.
    Sutton, Rosemary
    Venn, Nicola C.
    Marshall, Glenn M.
    Kees, Ursula R.
    Haber, Michelle
    Norris, Murray D.
    CELL CYCLE, 2008, 7 (10) : 1315 - 1320
  • [29] Pediatric acute lymphoblastic leukemia: Redefining outcomes
    Kadan-Lottick, N
    Neglia, JP
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 88 - 88
  • [30] Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia
    Wu, Chuan
    Li, Wei
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 126 : 100 - 111